Asparawem 5000Iu Dry Vial Of 1 Powder For Injection

• If you have a history of severe hypersensitivity to or any of the inactive ingredients.
• If you have severely impaired liver function.
• If you currently have pancreatitis associated with previous asparaginase therapy.

• Hypersensitivity reactions (ranging from mild rash and hives to severe anaphylaxis)
• Blood clotting abnormalities (decreased clotting factors leading to an increased risk of bleeding or blood clots/thrombosis)
• Hyperglycemia (elevated blood sugar levels) and alterations in glucose tolerance
• Elevated liver enzymes and bilirubin
• Nausea, vomiting, and loss of appetite
• Fatigue and weakness
• Infections
• Low white blood cell counts (which may increase risk of infections), low platelets (increased tendency of bleeding), and anaemia

• Abdominal pain and digestive discomfort
• Weight loss
• Changes in lipid profiles on blood test (elevated cholesterol or triglycerides)
• Abnormal liver function tests

• Severe hypersensitivity reactions
• Severe pancreatitis (intense abdominal pain radiating to the back, with nausea and vomiting)
• Seizures, coma, and posterior reversible encephalopathy syndrome (a rare but serious brain condition causing headaches vision changes, confusion, and seizures )
• Severe liver toxicity or liver failure
• Reduced kidney function
• Severe thrombosis or bleeding, including potentially life-threatening blood clots

Other General Warnings

• You experience severe abdominal pain, nausea, and vomiting.
• You notice sudden swelling, pain, or redness in your arms or legs, or severe headaches, vision changes, confusion, or seizures.
• You develop signs of an allergic reaction, such as rash, wheezing, or low blood pressure during or after administration.
• You experience extreme thirst, frequent urination, or confusion, which may indicate high blood sugar.
• You develop unusual bleeding or bruising, as Asparawem powder for injection can affect blood clotting.
• You have liver problems or develop yellowing of the skin or eyes, dark urine, or severe weakness.

• It is given as an injection by a trained healthcare professional.
• Your doctor will determine the dose and treatment schedule according to your leukemia treatment protocol.
• Patients should never attempt to change, delay, skip, or repeat a dose on their own.

• Asparawem powder for injection should be stored refrigerated in its original carton to protect it from light.
• Trained healthcare staff handle and prepare it, and administer it shortly after reconstitution.
• Keep out of the reach of children and pets.
• Unused medicine or waste material should be disposed of according to local guidelines for medicinal waste

• Keep all scheduled blood test appointments so your doctor can monitor your clotting factors, liver enzymes, and blood sugar closely.
• Report any severe, sharp abdominal pain radiating to your back immediately as this can be an early sign of pancreatitis.
• Report unusual swelling, pain, or redness in your limbs, or breathlessness, or other symptoms that may indicate a blood clot.
• Seek immediate medical attention for sudden headaches, vision changes, confusion, or seizures, as these may indicate a serious neurological complication.
• Inform your doctor immediately if you get hives, rash, difficulty breathing, or facial swelling during or after your injection.

Overdose

• There is no specific antidote for Asparawem powder for injection overdose.
• Overdose is unlikely as the medicine is given by a healthcare professional. If it occurs, supportive treatment and monitoring should be provided by your doctor.

Missed a Dose

• If you miss a scheduled dose or treatment session, contact your hospital immediately to reschedule.
• Do not attempt to make up a missed dose on your own.

Interactions with other medicines

• Methotrexate or cytarabine: The order in which these medicines are given with Asparawem powder for injection can affect how well they work. Follow your prescribed chemotherapy schedule.
• Prednisone: Using it with Asparawem powder for injection may increase the risk of blood-clotting problems and other side effects.
• Vincristine: Careful scheduling is needed because giving Asparawem powder for injection first may increase vincristine-related side effects.
• Imatinib: Using it with Asparawem powder for injection may increase the risk of liver problems, so monitoring may be needed.
• Live vaccines: These should generally be avoided during treatment because your immune system may be weakened.
• Asparawem powder for injection should not be mixed with other medicines in the same syringe or infusion unless compatibility has been confirmed.
• Tell your doctor about all medicines, vitamins, supplements, and herbal products you take, especially those affecting blood sugar or blood clotting.